Brochure | July 10, 2019

Capsugel® Zephyr™: Dry-Powder Inhalation Capsule Portfolio Brochure

Source: Capsugel® | Lonza Pharma & Biotech

Given patient convenience and compatibility with a range of formulations and doses, capsule based dry-powder inhalation (DPI) technology is becoming the preferred DPI drug delivery platform for respiratory and systemic applications. Lonza’s Capsugel® customized capsules, in both gelatin and hypromellose, are optimized to provide superior performance and compatibility between the capsule/device and capsule/formulation. To learn more about their DPI portfolio and customized approach, download the brochure.

access the Brochure!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests: